Corazon (Corsee) D. Sanders, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 584 shares at $40.98 ($24K) on 2024-07-02, disclosed to the SEC on 2024-07-03.
Open-market sale of $24k RARE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ONC | SELL | 2025-12-01 | $1.8M | — | Filing → |
| ONC | SELL | 2025-09-09 | $898K | — | Filing → |
| RARE | SELL | 2025-06-23 | $180K | — | Filing → |